NovaQuest Capital Management: Argenta Enters $30 Million Product Financing Agreement with NovaQuest to Accelerate New Veterinary Product Development
(0) Argenta Limited ("Argenta"), the only global contract research organization (CRO) and contract development and manufacturing organization (CDMO) specializing in animal health, and NovaQuest Capital Management ("NovaQuest") announced today a $30 million product financing agreement for the development of several innovative veterinary pharmaceuticals. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210520005132/en/ The collaboration leverages NovaQuest's capital and expertise, and Argenta's knowledge and know-how in research and de...